CCR5 Mutations Distinguish N-Terminal Modifications of RANTES (CCL5) with Agonist versus Antagonist Activity

CCR5 is the major HIV-1 entry coreceptor. RANTES/CCL5 analogs are more potent inhibitors of infection than native chemokines; one class activates and internalizes CCR5, one neither activates nor internalizes, and a third partially internalizes without activation. Here we show that mutations in CCR5...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Choi, Won-Tak, Nedellec, Rebecca, Coetzer, Mia, Colin, Philippe, Lagane, Bernard, Offord, Robin E., Hartley, Oliver, Mosier, Donald E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2012
Gaiak:
Vaccines and Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3446584/
https://ncbi.nlm.nih.gov/pubmed/22787219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00353-12
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak